The Role of Gemcitabine/S-1 in the Neoadjuvant Setting for Locally Advanced Pancreatic Cancer

被引：0
|
作者：
Kinoshita, S. [1 ]
Sho, M. [1 ]
Takahiro, A. [1 ]
Nomi, T. [1 ]
Yamato, I. [1 ]
Hokuto, D. [1 ]
Yasuda, S. [1 ]
Nakajima, Y. [1 ]
机构：
[1] Nara Med Univ, Dept Surg, Kashihara, Nara 634, Japan
来源：
PANCREAS | 2012年 / 41卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1157 / 1157
页数：1
相关论文
共 50 条
  • [21] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
    Song, Hunho
    Han, Boram
    Park, Choong Kee
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Kim, In-Gyu
    Kim, Hyo Jung
    Jung, Joo Young
    Kim, Jung Han
    Kwon, Jung Hye
    Jang, Geundoo
    Kim, Ho Young
    Kim, Hyeong Su
    Choi, Dae Ro
    Zang, Dae Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 845 - 852
  • [22] GEMCITABINE AND S-1 COMBINATION THERAPY IN PATIENTS WITH ADVANCED STAGE OF PANCREATIC CANCER
    Ouchi, J.
    Hijioka, M.
    Harada, S.
    Maruyama, Y.
    Funakoshi, A.
    PANCREAS, 2008, 37 (04) : 488 - 488
  • [23] A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma
    Kondo, Naru
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Nakagawa, Naoya
    Takahashi, Shinya
    Ohge, Hiroki
    Sueda, Taijiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (04) : 775 - 781
  • [24] Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer
    Yamauchi, Junichi
    Kanai, Masashi
    Matsumoto, Shigemi
    Nishimura, Takafumi
    Yazumi, Shujiro
    Kami, Kazuhiro
    Kawaguchi, Yoshiya
    Yasuda, Hiroyasu
    Kitano, Toshiyuki
    Misawa, Akiko
    Ishiguro, Hiroshi
    Yoshikawa, Kiyotsugu
    Yanagihara, Kazuhiro
    Fukushima, Masanori
    Doi, Ryuichiro
    Chiba, Tsutomu
    PANCREAS, 2008, 36 (03) : 327 - 328
  • [25] Pathological complete response in a patient with locally advanced pancreatic adenocarcinoma treated with neoadjuvant gemcitabine and S-1: a case report and literature review
    Hua, Surong
    Gao, Junyi
    Xu, Qiang
    Hong, Xiafei
    Wu, Wenming
    GLAND SURGERY, 2022, 11 (02) : 494 - 503
  • [26] NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer
    Sahora, Klaus
    Kuehrer, Irene
    Eisenhut, Axel
    Akan, Belgin
    Koellblinger, Claus
    Goetzinger, Peter
    Teleky, Bela
    Jakesz, Raimund
    Peck-Radosavljevic, Markus
    Ba'ssalamah, Ahmed
    Zielinski, Christoph
    Gnant, Michael
    SURGERY, 2011, 149 (03) : 311 - 320
  • [27] NeoGemTax: Gemcitabine and Docetaxel as Neoadjuvant Treatment for Locally Advanced Nonmetastasized Pancreatic Cancer
    Sahora, Klaus
    Kuehrer, Irene
    Schindl, Martin
    Koelblinger, Claus
    Goetzinger, Peter
    Gnant, Michael
    WORLD JOURNAL OF SURGERY, 2011, 35 (07) : 1580 - 1589
  • [28] NeoGemTax: Gemcitabine and Docetaxel as Neoadjuvant Treatment for Locally Advanced Nonmetastasized Pancreatic Cancer
    Klaus Sahora
    Irene Kuehrer
    Martin Schindl
    Claus Koelblinger
    Peter Goetzinger
    Michael Gnant
    World Journal of Surgery, 2011, 35 : 1580 - 1589
  • [29] Improved survival with combined gemcitabine and S-1 for locally advanced pancreatic cancer: pooled analysis of three randomized studies
    Yanagimoto, Hiroaki
    Ishii, Hiroshi
    Nakai, Yousuke
    Ozaka, Masato
    Ikari, Takaaki
    Koike, Kazuhiko
    Ueno, Hideki
    Ioka, Tatsuya
    Satoi, Sohei
    Sho, Masayuki
    Okusaka, Takuji
    Tanaka, Masao
    Shimokawa, Toshio
    Kwon, A-Hon
    Isayama, Hiroyuki
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2014, 21 (10) : 761 - 766
  • [30] A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer
    Kohei Nakachi
    Junji Furuse
    Taira Kinoshita
    Mitsuhiko Kawashima
    Hiroshi Ishii
    Masafumi Ikeda
    Shuichi Mitsunaga
    Satoshi Shimizu
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 527 - 534
12345